Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial.

Creators: MURIALDO, ROBERTO; Bertolotti F; Pastorino G; Mencoboni M; Bergaglio M; Folco U; Cinzia N; Vaira F; Simoni C; Canobbio L; Parodi M; Brema F; BALLESTRERO, ALBERTO

Others:: Murialdo, Roberto; Bertolotti, F; Pastorino, G; Mencoboni, M; Bergaglio, M; Folco, U; Cinzia, N; Vaira, F; Simoni, C; Canobbio, L; Parodi, M; Brema, F; Ballestrero, Alberto

Additional details